Stifel Financial
MBOT icon

Stifel Financial’s Microbot Medical MBOT Stock Holding History

Stifel Financial’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.38M Buy
573,075
+307,085
+115% +$686K ﹤0.01% 2217
2025
Q4 		$532K Buy
265,990
+108,498
+69% +$257K ﹤0.01% 2825
2025
Q3 		$480K Buy
157,492
+141,388
+878% +$441K ﹤0.01% 2837
2025
Q2 		$40.6K Buy
16,104
+5,445
+51% +$13K ﹤0.01% 3425
2025
Q1 		$16.1K Buy
10,659
+339
+3% +$599 ﹤0.01% 3402
2024
Q4 		$11.6K Sell
10,320
-1
-0% -$1 ﹤0.01% 3364
2024
Q3 		$9.23K Hold
10,321
– – ﹤0.01% 3355
2024
Q2 		$10.5K Hold
10,321
– – ﹤0.01% 3347
2024
Q1 		$12.7K Hold
10,321
– – ﹤0.01% 3323
2023
Q4 		$16.9K Buy
+10,321
New +$13.7K ﹤0.01% 3279

Other funds holding MBOT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Stifel Financial's MBOT Position: Q1 2026 in Review

Stifel Financial increased its Microbot Medical (MBOT) stake by 115% in Q1 2026, buying an estimated $686K and bringing the position to 573,075 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #2217.

Stifel Financial first reported a position in MBOT in Q4 2023 and has held it in 10 quarters since. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

  • Stifel Financial held 573,075 shares of Microbot Medical worth $1.38M as of Q1 2026.
  • Stifel Financial bought 307,085 Microbot Medical shares in Q1 2026, an estimated $686K.
  • Microbot Medical made up ﹤0.01% of Stifel Financial's portfolio in Q1 2026, its #2217 holding.
  • Stifel Financial first reported a position in Microbot Medical in Q4 2023 and has held it in 10 quarters since.
  • 79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.